163 related articles for article (PubMed ID: 27416039)
1. Age Disparities in the Use of Steroid-sparing Therapy for Inflammatory Bowel Disease.
Govani SM; Wiitala WL; Stidham RW; Saini SD; Hou JK; Feagins LA; Sussman JB; Higgins PD; Waljee AK
Inflamm Bowel Dis; 2016 Aug; 22(8):1923-8. PubMed ID: 27416039
[TBL] [Abstract][Full Text] [Related]
2. Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort.
Waljee AK; Wiitala WL; Govani S; Stidham R; Saini S; Hou J; Feagins LA; Khan N; Good CB; Vijan S; Higgins PD
PLoS One; 2016; 11(6):e0158017. PubMed ID: 27336296
[TBL] [Abstract][Full Text] [Related]
3. Older age and steroid use are associated with increasing polypharmacy and potential medication interactions among patients with inflammatory bowel disease.
Parian A; Ha CY
Inflamm Bowel Dis; 2015 Jun; 21(6):1392-400. PubMed ID: 25856768
[TBL] [Abstract][Full Text] [Related]
4. Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.
Everhov ÅH; Halfvarson J; Myrelid P; Sachs MC; Nordenvall C; Söderling J; Ekbom A; Neovius M; Ludvigsson JF; Askling J; Olén O
Gastroenterology; 2018 Feb; 154(3):518-528.e15. PubMed ID: 29102619
[TBL] [Abstract][Full Text] [Related]
5. Myelosuppression monitoring after immunomodulator initiation in veterans with inflammatory bowel disease: a national practice audit.
Hou JK; Kramer JR; Richardson P; Sansgiry S; El-Serag HB
Aliment Pharmacol Ther; 2012 Dec; 36(11-12):1049-56. PubMed ID: 23061548
[TBL] [Abstract][Full Text] [Related]
6. Trends in Narcotic and Corticosteroid Prescriptions in Patients with Inflammatory Bowel Disease in the United States Ambulatory Care Setting from 2003 to 2011.
Narula N; Borges L; Steinhart AH; Colombel JF
Inflamm Bowel Dis; 2017 Jun; 23(6):868-874. PubMed ID: 28368911
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Vedolizumab in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients.
Khan N; Pernes T; Weiss A; Trivedi C; Patel M; Medvedeva E; Xie D; Yang YX
Inflamm Bowel Dis; 2022 May; 28(5):734-744. PubMed ID: 34245261
[TBL] [Abstract][Full Text] [Related]
8. Assessment of steroid use as a key performance indicator in inflammatory bowel disease-analysis of data from 2385 UK patients.
Selinger CP; Parkes GC; Bassi A; Limdi JK; Ludlow H; Patel P; Smith M; Saluke S; Ndlovu Z; George B; Saunders J; Adamson M; Fraser A; Robinson J; Donovan F; Parisi I; Tidbury J; Gray L; Pollok R; Scott G; Raine T
Aliment Pharmacol Ther; 2019 Nov; 50(9):1009-1018. PubMed ID: 31595533
[TBL] [Abstract][Full Text] [Related]
9. Incidence of Infections and Malignancy Among Elderly Male Patients with IBD Exposed to Vedolizumab, Prednisone, and 5-ASA Medications: A Nationwide Retrospective Cohort Study.
Khan N; Pernes T; Weiss A; Trivedi C; Patel M; Xie D; Yang YX
Adv Ther; 2021 May; 38(5):2586-2598. PubMed ID: 33844132
[TBL] [Abstract][Full Text] [Related]
10. Trends in Medication Prescribing in Patients With PTSD From 2009 to 2018: A National Veterans Administration Study.
Holder N; Woods A; Neylan TC; Maguen S; Seal KH; Bernardy N; Wiechers I; Ryder A; Urbieta AM; Cohen BE
J Clin Psychiatry; 2021 May; 82(3):. PubMed ID: 34004087
[TBL] [Abstract][Full Text] [Related]
11. Risk of Malignancy in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients.
Khan N; Vallarino C; Lissoos T; Darr U; Luo M
Drugs Aging; 2017 Nov; 34(11):859-868. PubMed ID: 29170864
[TBL] [Abstract][Full Text] [Related]
12. Assessing potentially inappropriate prescribing in the elderly Veterans Affairs population using the HEDIS 2006 quality measure.
Pugh MJ; Hanlon JT; Zeber JE; Bierman A; Cornell J; Berlowitz DR
J Manag Care Pharm; 2006 Sep; 12(7):537-45. PubMed ID: 16981799
[TBL] [Abstract][Full Text] [Related]
13. The Association of Medications and Vaccination with Risk of Pneumonia in Inflammatory Bowel Disease.
Gregory MH; Ciorba MA; Wiitala WL; Stidham RW; Higgins P; Morley SC; Hou JK; Feagins LA; Govani SM; Cohen-Mekelburg SA; Waljee AK
Inflamm Bowel Dis; 2020 May; 26(6):919-925. PubMed ID: 31504531
[TBL] [Abstract][Full Text] [Related]
14. Impact of an Integrated Model of Care on Outcomes of Patients With Inflammatory Bowel Diseases: Evidence From a Population-Based Study.
Peña-Sánchez JN; Lix LM; Teare GF; Li W; Fowler SA; Jones JL
J Crohns Colitis; 2017 Dec; 11(12):1471-1479. PubMed ID: 28981633
[TBL] [Abstract][Full Text] [Related]
15. Market share and costs of biologic therapies for inflammatory bowel disease in the USA.
Yu H; MacIsaac D; Wong JJ; Sellers ZM; Wren AA; Bensen R; Kin C; Park KT
Aliment Pharmacol Ther; 2018 Feb; 47(3):364-370. PubMed ID: 29164650
[TBL] [Abstract][Full Text] [Related]
16. Predicting Hospitalization and Outpatient Corticosteroid Use in Inflammatory Bowel Disease Patients Using Machine Learning.
Waljee AK; Lipson R; Wiitala WL; Zhang Y; Liu B; Zhu J; Wallace B; Govani SM; Stidham RW; Hayward R; Higgins PDR
Inflamm Bowel Dis; 2017 Dec; 24(1):45-53. PubMed ID: 29272474
[TBL] [Abstract][Full Text] [Related]
17. Current practice and perception of screening for medication adherence in inflammatory bowel disease.
Trindade AJ; Morisky DE; Ehrlich AC; Tinsley A; Ullman TA
J Clin Gastroenterol; 2011; 45(10):878-82. PubMed ID: 21555953
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic Medication Prescriptions for Homeless and Unstably Housed Veterans in the Veterans Affairs Health Care System.
Tsai J; Szymkowiak D; Radhakrishnan R
J Clin Psychiatry; 2020 Dec; 82(1):. PubMed ID: 33296148
[TBL] [Abstract][Full Text] [Related]
19. Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD Registry.
Agrawal M; Brenner EJ; Zhang X; Colombel JF; Kappelman MD; Ungaro RC; ; Gearry RB; Kalpan GG; Kissous-Hunt M; Lewis JD; Ng SC; Rahier JF; Reinisch W; Ruemmele FM; Steinwurz F; Underwood FE
J Crohns Colitis; 2021 May; 15(5):860-863. PubMed ID: 33232456
[TBL] [Abstract][Full Text] [Related]
20. Dual therapy with infliximab and immunomodulator reduces one-year rates of hospitalization and surgery among veterans with inflammatory bowel disease.
Abraham NS; Richardson P; Castillo D; Kane SV
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1281-7. PubMed ID: 23792295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
